Chimin Health Management Co Ltd
603222
Company Profile
Business description
Chimin Health Management Co Ltd is engaged in the pharmaceutical industry. It is engaged in the research and development, production and sales of human medicines and medical devices. Its product centers include large volume injection, medical instruments, Nephrology treatment, and medical service. The company has production bases in Taizhou, Shanghai and Spain.
Contact
No. 888, Beiyuan Road
Huangyan District, Zhejiang Province
Taizhou318020
CHNT: +86 57684066800
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
1,994
Stocks News & Analysis
stocks
We remove our Moat Rating from ASX listed share
Despite a surging share price a weakening competitive position causes a reassessment of our view.
stocks
Best sustainable companies to own in 2026
We believe these companies’ strong ESG management practices give them a long-term advantage.
stocks
New data centre deal for ASX listed REIT
New parternship adds to a growing data centre pipeline in fiscal 2026.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,034.70 | 2.20 | -0.02% |
| CAC 40 | 8,217.96 | 22.75 | 0.28% |
| DAX 40 | 24,729.08 | 189.74 | 0.77% |
| Dow JONES (US) | 48,382.39 | 319.10 | 0.66% |
| FTSE 100 | 9,968.79 | 17.65 | 0.18% |
| HKSE | 26,347.24 | 8.77 | 0.03% |
| NASDAQ | 23,235.63 | 6.36 | -0.03% |
| Nikkei 225 | 51,832.80 | 1,493.32 | 2.97% |
| NZX 50 Index | 13,587.23 | 38.81 | 0.29% |
| S&P 500 | 6,858.47 | 12.97 | 0.19% |
| S&P/ASX 200 | 8,728.60 | 2.60 | 0.03% |
| SSE Composite Index | 4,023.42 | 54.58 | 1.38% |